When teams treat AI as a tool for insight rather than full automation, and keep human judgment at the center, adoption ...

Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...

More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...

Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...

Researchers developed and validated a non-invasive urinary microRNA aging clock using extracellular vesicle miRNAs from more ...

Because non-terrestrial networks must perform reliably to support high-speed internet, they require a dedicated test ...

Adaptive test is starting to gain traction for high-performance computing and AI chips as test programs that rely on static limits and fixed test sequences reach their practical limits.

Riding MLB’s surge in analytics, Full Swing debuts KIT for baseball, a monitor aimed at coaches, teams and training ...

As backtesting becomes a more standard part of responsible crypto trading, platforms offering reliable historical data and ...

Bayer is deploying GenAI tools at scale while many corporates struggle to find ROI on AI. The difference may lie in a 12-year-old acquisition ...

By blending AI, behavioural insights, and synthetic data, financial institutions can build more resilient, transparent, and ...